A contract research organization providing drug discovery and development services to pharmaceutical and biotechnology companies. Investors monitor its performance due to exposure to preclinical research demand and regulatory shifts affecting outsourced R&D.
1 member of Congress has disclosed 2 trades in Inotiv, Inc. (NOTV), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-12-12 | Christopher L. Jacobs | sell | $1K – $15K |
| 2022-07-18 | Christopher L. Jacobs | buy | $1K – $15K |